Total Debt Summary of Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc.'s latest annual total debt in 2023 was 1.4 Million TWD , down -47.68% from previous year.
Alar Pharmaceuticals Inc.'s latest quarterly total debt in 2024 Q2 was 759 Thousand TWD , down -29.85% from previous quarter.
Alar Pharmaceuticals Inc. reported annual total debt of 2.69 Million TWD in 2022, up 183.77% from previous year.
Alar Pharmaceuticals Inc. reported annual total debt of 949 Thousand TWD in 2021, down -37.48% from previous year.
Alar Pharmaceuticals Inc. reported quarterly total debt of 759 Thousand TWD for 2024 Q2, down -29.85% from previous quarter.
Alar Pharmaceuticals Inc. reported quarterly total debt of 1.73 Million TWD for 2023 Q3, down -15.66% from previous quarter.

Annual Total Debt Chart of Alar Pharmaceuticals Inc. (2023 - 2019)

Name	Total Debt	Total Debt Difference
Allied Biotech Corporation	796.6 Million TWD	99.823%
GeneFerm Biotechnology Co., Ltd.	152.07 Million TWD	99.074%
Easywell Biomedicals, Inc.	386.34 Million TWD	99.635%
TTY Biopharm Company Limited	1.91 Billion TWD	99.926%
Synmosa Biopharma Corporation	2.43 Billion TWD	99.942%
Orient EuroPharma Co., Ltd.	4.84 Billion TWD	99.971%
Center Laboratories, Inc.	5.62 Billion TWD	99.975%
Tien Liang BioTech Co., Ltd.	84.65 Million TWD	98.336%
Orient Pharma Co., Ltd.	716.92 Million TWD	99.803%
InnoPharmax Inc.	21.49 Million TWD	93.446%
Johnson Chemical Pharmaceutical Works Co., Ltd.	160.83 Million TWD	99.124%
Excelsior Biopharma Inc.	377.4 Million TWD	99.627%
DV Biomed Co., Ltd.	387.69 Million TWD	99.637%
Foresee Pharmaceuticals Co., Ltd.	228.25 Million TWD	99.383%
Handa Pharmaceuticals, Inc.	13.24 Million TWD	89.358%
UniPharma Co., Ltd.	277 Thousand TWD	-408.664%
Anxo Pharmaceutical Co., Ltd.	787.84 Million TWD	99.821%
Winston Medical Supply Co., Ltd.	107.32 Million TWD	98.687%
Mercury Biopharmaceutical Corporation	42.34 Million TWD	96.673%
Bioray Biotech Co., Ltd	69.79 Million TWD	97.981%
TSH Biopharm Corporation Limited	7.84 Million TWD	82.035%